Additionally, flow cytometry validation, while robust for NKt-AML, did not comprehensively cover all cytogenetic subgroups that showed high IL1RAP expression in our omics analyses, particularly t(8;21) and t(6;9) AML. The gene discussed is IL1RAP; the disease is acute myeloid leukemia.